Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07167940 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days

Study acronym: RAPID5
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Jun 30, 2030 → Sep 30, 2030
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from VA Office of Research and Development

Record History

  1. Primary endpoint(s) modified Start date: Oct 1, 2026 to Nov 16, 2026 · Eligibility criteria expanded, about 36 words · Secondary endpoints: details revised at 3 of 3 entries Show 3 more changesShow less
    • Start date: Oct 1, 2026 to Nov 16, 2026
    • Eligibility criteria expanded, about 36 words
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Primary completion pushed from Jun 30, 2030 to Sep 30, 2030 Completion pushed from Jul 1, 2030 to Dec 6, 2030 · Site contacts updated at 1 of 2 sitesv4 Show 2 more changesShow less
    • Completion pushed from Jul 1, 2030 to Dec 6, 2030
    • Site contacts updated at 1 of 2 sites
  3. Start date: Jul 1, 2026 to Oct 1, 2026 Primary completion date: Jun 30, 2030 to Sep 30, 2030 · Completion date: Jul 1, 2030 to Dec 6, 2030 · Eligibility criteria shortened, about 11 wordsv3 Show 3 more changesShow less
    • Primary completion date: Jun 30, 2030 to Sep 30, 2030
    • Completion date: Jul 1, 2030 to Dec 6, 2030
    • Eligibility criteria shortened, about 11 words

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Mar 9, 2026 to Jul 1, 2026 Primary completion date: Jan 9, 2030 to Jun 30, 2030 · Completion date: Feb 2, 2030 to Jul 1, 2030v2 Show 2 more changesShow less
    • Primary completion date: Jan 9, 2030 to Jun 30, 2030
    • Completion date: Feb 2, 2030 to Jul 1, 2030
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Veterans with posttraumatic stress disorder (PTSD) need more effective treatments. Existing options can have limited adherence and can be very time-consuming. As such, alternative interventions are needed. Transcranial magnetic stimulation (TMS) has been FDA-cleared for depression since 2008 and has recently been cleared to treat smoking cessation and obsessive-compulsive disorder. It has demonstrated promise for reducing PTSD symptom severity but standard TMS has a significant time requirement. This study will compare an accelerated 5-day form of TMS versus sham for PTSD, characterizing efficacy and durability. This project will provide important information that can be implemented in the near term for Veterans with PTSD.
Trial Details
NCT Number NCT07167940
Lead Sponsor VA Office of Research and Development
Conditions PTSD
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov